Neoadjuvant FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: A phase II multicentre randomised controlled trial (PRODIGE 22)
| Affiliation auteurs | Affiliation ok |
| Titre | Neoadjuvant FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: A phase II multicentre randomised controlled trial (PRODIGE 22) |
| Type de publication | Journal Article |
| Year of Publication | 2017 |
| Auteurs | Karoui M., Rullier A., Mariette C., Maillard E., Bardier A., Poizat F., Luciani A., Sarran A., Legoux J-L., De Chaisemartin C., Lecaille C., Bouche O., Mauvais F., Brunetti F., Prudhomme M., Seitz J-F., Lepage C., Taieb J. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 28 |
| Date Published | SEP |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |